Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.
Apmonia Therapeutics has raised $7.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Apmonia Therapeutics's investors include Bpifrance, EIC Accelerator, France 2030.
Apmonia Therapeutics is headquartered in Reims, France.
Apmonia Therapeutics is a biotech company that develop therapeutic strategies towards multiple types of cancer.
Apmonia Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Apmonia Therapeutics — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/apmonia-therapeutics. Accessed July 20, 2026.
VCBacked. (2024). Apmonia Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/apmonia-therapeutics
{{cite web |title=Apmonia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/apmonia-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated